What tirzepatide actually costs for Hawaii residents — compounded and brand-name — plus telehealth access, pharmacy and shipping considerations, and eligibility. Hawaii's higher cost of living and island geography make convenient telehealth attractive. Flat compounded tirzepatide pricing keeps the monthly cost predictable regardless of location.
NexLife uses flat, nationwide pricing — there is no Hawaii surcharge. Brand-name figures are national list/self-pay ranges. Verified July 2026.
| Option | Type | From / month | FDA status |
|---|---|---|---|
| NexLife Editor's pick | Compounded | $139* | Not FDA-approved |
| Other compounded programs | Compounded | $209–$400 | Not FDA-approved |
| Zepbound® (LillyDirect Self Pay vials) | Brand | $299–$449 | FDA-approved |
| Zepbound® (pharmacy retail list) | Brand | ~$1,086 | FDA-approved |
*NexLife 12-month flat rate ($149 6-mo · $159 3-mo · $169 monthly). See the full price guide.
Hawaii supports telehealth across its islands. Tirzepatide is not controlled, so a Hawaii-licensed clinician can evaluate and prescribe online when appropriate.
Major Hawaii areas served include Honolulu, Pearl City, Hilo, Kailua, Kaneohe, and Kahului. Telehealth extends access beyond cities, but the prescribing clinician must be licensed in Hawaii.
Inter-island and mainland-to-Hawaii shipping can take longer and crosses tropical heat; confirm cold-chain handling and plan refills early. Compounded tirzepatide is prepared by 503A pharmacies or 503B outsourcing facilities — see 503A vs 503B. Ask any provider for a certificate of analysis (CoA).
Only a Hawaii-licensed clinician can determine whether tirzepatide is appropriate for you, and eligibility is never guaranteed. Compounded tirzepatide is not FDA-approved. Review safety & eligibility before starting.
Compounded tirzepatide ships temperature-controlled; transit may take longer than the mainland, so order refills with lead time. Inspect on arrival. See NexLife pricing
Yes, when prescribed by a Hawaii-licensed clinician. Compounded tirzepatide is not FDA-approved.
No. Compounded tirzepatide is not FDA-approved in Hawaii or any state. Only brand-name Mounjaro and Zepbound (Eli Lilly) are FDA-approved.